Remove Ethics Remove Healthcare Remove Medicine
article thumbnail

How Artificial Intelligence Could Be the Ultimate Weapon Against Cancer

MedCity News

Artificial intelligence (AI) is rapidly transforming the healthcare industry, with its ability to process and analyze vast amounts of data. One example of how AI is already being used to personalize cancer treatment is in the field of precision medicine. Even just a year ago, we couldn’t fathom a cure for cancer. Now, we can.

article thumbnail

Pharma Research Trends: Leveraging Innovation for Smarter Marketing Strategies

Pharma Marketing Network

From AI-powered insights to the rise of precision medicine, new trends are reshaping the way we connect with patients and healthcare providers. Precision Medicine: Targeting the Right Audience Precision medicine, with its focus on individualized treatment, offers a goldmine of opportunities for marketers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Canadian and US developers to trial psychedelic medicines in UK

European Pharmaceutical Review

The UK’s regulatory pathway and fast-track drug approval process enables companies to fast-track their ethics applications and combine their reviews. The regulators are the Medicines and Healthcare products Regulatory Agency (MHRA) and US Food and Drug Administration (FDA) respectively.

Medicine 105
article thumbnail

Mastering Medical Proficiency: Crafting Competency-Based Training Programs in Healthcare

Infuse Medical

The demand for highly qualified individuals is never stronger in the fast-paced and always changing environment of healthcare. Competency-based training healthcare is a novel method emphasizing on the acquisition of the exact skills and information required for healthcare professionals to perform in their positions.

Training 130
article thumbnail

Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets

PM360

Access to medicines have persisting and systemic differences across the globe and within countries. It is estimated that nearly two billion people globally do not have access to essential medicines. Traditionally, pharmaceutical companies have not prioritized emerging markets as part of their access strategy.

article thumbnail

Staying abreast of regulations with NGS?based viral safety for faster, safer and more ethical lot release of our vaccines

European Pharmaceutical Review

As the healthcare sector grows, there is a clear trend towards the expansion of biologic therapeutic drugs and vaccines like the one developed by Novavax. Novavax is particularly sensitive to this matter and is looking for alternatives that will not only benefit the patients but align with a more ethical solution.

Ethics 98
article thumbnail

Pharma Marketing in 2025: Talking Trends With Angela Tenuta

Eversana Intouch

Applied AI Although AI promises a great return on investment, the pharma industry has been slow to adopt it due to ethical, regulatory, and compliance hurdles. Angela Tenuta Globalization and Health Equity Healthcare systems face challenges, including rising chronic diseases, aging populations, workforce shortages and sustainability concerns.